newsfilter
← Latest News
Business Wire·

Cyteir Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference

Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, announced that its President and Chief Executive Officer Markus Renschler, MD, will prese